Narcolepsy with Cataplexy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-05-21
Clinical Trial Update: A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1 [Phase 3]
This is a clinical trial update describing a Phase 3 study of NLS-2, mazindol extended release, for Narcolepsy Type 1 (with cataplexy), whic…